AI assistant
Microbot Medical Inc. — Director's Dealing 2013
May 18, 2013
33819_dirs_2013-05-17_de4c14a2-f1c7-44bb-9809-3dc53b3690f8.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: STEMCELLS INC (STEM)
CIK: 0000883975
Period of Report: 2013-05-15
Reporting Person: TSUKAMOTO ANN (EVP, Research and Development)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2013-05-15 | Common Stock | F | 1245 | $1.84 | Disposed | 161094 | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 3643 | Indirect |
| Common Stock | 16692 | Indirect |
Footnotes
F1: This is recorded as a Code F disposition because the shares were used by the reporting person to pay a tax liability incurred by her from the delivery of shares incident to the vesting of restricted stock units.
F2: Includes (1) 86,666 restricted stock units, with 43,333 vesting on each of January 27, 2014 and January 27, 2015; and (2) 23,333 restricted stock units vesting on June 1, 2013.
F3: 3,643 shares held in trust as to which Dr. Tsukamoto disclaims beneficial ownership.
F4: Shares held in 401(k) account in accordance with issuer's employer-match policies.